Calvin Sandra sold TVTX
December 15, 2025 · Form 4 insider transaction
Calvin Sandra sold 2,910 shares of Travere Therapeutics, Inc. at $36.00 per share, a transaction worth $104.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,910
Price
$36.00
Total value
$104.8K
InsiderCalvin Sandra
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 15, 2025
Filing dateDecember 16, 2025
Shares owned after45,635
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on June 10, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.